Vengoji and colleagues recently reported that BBR has anti-tumor effects through inhibition of the mTOR-signaling pathway and can induce senescence of human glioblastoma cells by downregulating the EGFR–MEK–ERK signaling pathway [41]. The gene discussed is MAP2K7; the disease is glioblastoma.